Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 20/20 | 0.53 |
| ▸ | FNTB | P49356 | 20/20 | 0.53 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6760839 | 0.89 | FNTA (0.44) | FNTAFNTBPGGT1B | |
| Trifluoroacetic Acid SCHEMBL6757258 | 0.78 | ADRA1A (0.43) | FNTAFNTBPGGT1B | |
| SCHEMBL6613124 | 0.71 | ADRA1A (0.48) | — | |
| Trifluoroacetic Acid SCHEMBL16111192 | 0.70 | FNTA (0.91) | FNTAFNTBPGGT1B | |
| SCHEMBL6760847 | 0.68 | FNTA (0.53) | FNTAFNTBPGGT1B | |
| Trifluoroacetic Acid SCHEMBL6756379 | 0.67 | FNTA (0.48) | FNTAFNTBPGGT1B | |
| SCHEMBL7258579 | 0.66 | FNTA (0.55) | FNTAFNTBPGGT1B | |
| Trifluoroacetic Acid SCHEMBL6756412 | 0.65 | FNTA (0.46) | FNTAFNTBPGGT1B | |
| SCHEMBL21828638 | 0.64 | CYP3A4 (0.58) | FNTAFNTBPGGT1B | |
| SCHEMBL17548810 | 0.64 | FNTA (1.00) | FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040204417-A1 | Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins | PIERRE FABRE MEDICAMENT (FR) | 2004-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204417-A1 | Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins | CBR1, CBR3, HCCS | FNTA 338/4885FNTB 215/4885PGGT1B 905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.